Target intelligence / Profile preview

Neurophysin II (NPII)

Target
NPII
Molecular classification
Carrier protein, Chaperone-like protein, Hormone precursor
01

Overview

Neurophysin II is a 10-kDa carrier protein that is essential for the synthesis, transport, and storage of the hormone arginine vasopressin (AVP). Both AVP and neurophysin II are derived from a common precursor protein, prepro-vasopressin-neurophysin II, which is synthesized in the magnocellular neurons of the hypothalamus. Within the hypothalamic-neurohypophyseal system, neurophysin II binds to AVP to form a stable complex that protects the hormone from proteolytic degradation and facilitates its axonal transport to the posterior pituitary gland. Mutations in the gene encoding this protein lead to misfolding and accumulation within the endoplasmic reticulum, causing the death of vasopressinergic neurons and resulting in familial neurohypophyseal diabetes insipidus. While not a direct target for traditional pharmacological agonists or antagonists, it is a critical focus for research into protein-misfolding diseases and serves as a biomarker for neurohypophyseal function.

Other names
Vasopressin-associated neurophysinVasopressin-neurophysin 2-copeptinNeurophysin-IIAVP-NPIIPrepro-AVP
02

Mechanism of action

Neurophysin II functions by non-covalently binding the hormone arginine vasopressin within neurosecretory granules, ensuring its stability and correct trafficking from the site of synthesis in the hypothalamus to the site of release in the posterior pituitary.

03

Biological functions

Carrier proteinHormone transportIntracellular traffickingProtein foldingPrecursor processing
04

Disease associations

Familial neurohypophyseal diabetes insipidus (FNDI)Hereditary hypothalamic diabetes insipidusDiabetes insipidusSmall cell lung cancer (SIADH biomarker)
05

Safety considerations

Protein misfolding and neurotoxicityER stress-induced apoptosis of hypothalamic neuronsGenetic susceptibility to water balance disorders
06

Biomarkers

CopeptinNeurophysin IIArginine vasopressin (AVP)

Beyond the preview

Go deeper on Neurophysin II (NPII).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neurophysin II (NPII).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call